Efficacy and safety of the dipeptidyl peptidase-4 inhibitor gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
Rhee, E. J., Lee, W. Y., Min, K. W., Shivane, V. K., Sosale, A. R., Jang, H. C., Chung, C. H., Nam-Goong, I. S., Kim, J. A., Kim, S. W.Volume:
15
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12060
Date:
June, 2013
File:
PDF, 509 KB
english, 2013